ストックスクリーナーアプリを入手
0.2132
0.61%
0.0011
前日終値:
$0.2143
開ける：
$0.21
24時間の取引高:
1.08M
Relative Volume:
0.17
時価総額：
$196.03M
収益：
$420.00K
当期純損益:
$-35.84M
株価収益率:
-0.0359
EPS:
-5.9381
ネットキャッシュフロー:
$-32.12M
1週間 パフォーマンス:
-12.32%
1か月 パフォーマンス:
-43.26%
6か月 パフォーマンス:
-98.87%
1年 パフォーマンス:
-96.72%
1日の値動き範囲:
$0.21
$0.2224
1週間の範囲:
$0.21
$0.2497
52週間の値動き範囲:
$0.21
$20.60
Kala Bio Inc Stock (KALA) Company Profile
Compare KALA vs VRTX, REGN, ALNY, ARGX, INSM
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
KALA
Kala Bio Inc
|
0.2151 | 195.30M | 420.00K | -35.84M | -32.12M | -5.9381 |
VRTX
Vertex Pharmaceuticals Inc
|
455.98 | 115.58B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
756.91 | 79.23B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
331.86 | 43.59B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
696.11 | 43.26B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
149.07 | 31.97B | 606.42M | -1.28B | -997.58M | -6.403 |
Kala Bio Inc Stock (KALA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-09-30 | ダウングレード | Mizuho | Outperform → Neutral |
| 2025-09-29 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2025-09-29 | ダウングレード | Ladenburg Thalmann | Buy → Neutral |
| 2025-09-08 | 開始されました | Mizuho | Outperform |
| 2025-07-11 | 開始されました | Ladenburg Thalmann | Buy |
| 2022-03-30 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2021-08-06 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2020-09-14 | ダウングレード | Jefferies | Buy → Hold |
| 2020-07-23 | 開始されました | Northland Capital | Outperform |
| 2020-06-01 | 再開されました | Oppenheimer | Outperform |
| 2020-05-27 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-03-09 | アップグレード | BofA/Merrill | Neutral → Buy |
| 2019-12-17 | ダウングレード | BofA/Merrill | Buy → Neutral |
| 2019-03-14 | 開始されました | Jefferies | Buy |
すべてを表示
Kala Bio Inc (KALA) 最新ニュース
Trading Action: Will KALA BIO Inc stock benefit from M A2026 Selloffs & Daily Entry Point Trade Alerts - baoquankhu1.vn
KALA BIO, Inc. (NASDAQ:KALA) Short Interest Up 600.0% in March - MarketBeat
Kala Bio rises on plans to leverage AI - MSN
If You Invested $1,000 in Kala Pharmaceuticals Inc (KALA) - Stock Titan
$180 Billion AI Healthcare Emerging Sector Highlighted by Red Light Holland’s Researgency.ai Platform for Biotech & Pharmaceutical Industry: KALA BIO, Inc. (Nasdaq: KALA) - Barchart.com
FinancialContent$180 Billion AI Healthcare Emerging Sector Highlighted by Red Light Holland’s Researgency.ai Platform for Biotech & Pharmaceutical Industry: KALA BIO, Inc. (Nasdaq: KALA) - FinancialContent
KALA BIO (KALA) Projected to Post Quarterly Earnings on Thursday - MarketBeat
KALA Engages AI Technology for Advancing Psilocybin Drug Development - GuruFocus
Red Light Holland Engages Kala Bio's Researgency.AI Platform to Support Clinical Development of Filament's Patented PEX010 Botanical Psilocybin Drug Candidate - Investing News Network
Red Light Holland Deploys Kala Bio AI Platform to Advance Psilocybin Drug PEX010 - TipRanks
Red Light Holland Engages Kala Bio’s Researgency.AI - GlobeNewswire
Red Light Holland Engages Kala Bio's Researgency.ai Platform to Support Clinical Development of Filament Health's Patented PEX010 Botanical Psilocybin Drug Candidate - TMX Newsfile
[144] KALA BIO, Inc. SEC Filing - Stock Titan
Stock Trend Capital Highlights Younet AI’s Exclusive Biotech Partnership with KALA BIO - TipRanks
KALA BIO to launch first commercial AI agent in two weeks - Investing.com Nigeria
KALA BIO, Inc. (NASDAQ:KALA) Short Interest Update - MarketBeat
Why Did KALA Stock Surge 25% Today? - Stocktwits
Form 144 KALA BIO For: 12 March By Investing.com - Investing.com Australia
Movement Recap: Does Dragonfly Energy Holdings Corp Equity Warrant have consistent dividend growthQuarterly Trade Report & Expert Curated Trade Ideas - baoquankhu1.vn
Morgan Stanley Smith Barney files Form 144 to sell restricted KALA shares (KALA) - Stock Titan
Form 144: Restricted stock sale notice — Kala Pharmaceuticals (NASDAQ: KALA) - Stock Titan
Highpeak Energy Posts Downbeat Q4 Results, Joins Netskope, Descartes Systems And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Benzinga
After Hours 11 Mar 2026: KALA BIO (KALA NASDAQ) up 24.16% to $0.36, model sees upside - Meyka
Younet.ai Highlights Researgency.ai Collaboration with Kala Bio (KALA) as New "AutoResearch" Milestone Signals the Rise of Autonomous Research Agents - The Globe and Mail
KALA BIO (KALA) Stock Jumps 70% After Pivoting to AI With ‘Palantir for Biotech’ Vision - MEXC
KALA BIO's 70% Surge: Flow Analysis of the AI Pivot - Bitget
Kala Bio Announces Launch Of First Commercial AI Product - marketscreener.com
KALA BIO (KALA) Stock Soars 70% on AI Agent Launch and ‘Palantir for Biotech’ Strategy - Blockonomi
Why Did KALA Stock Surge 70% In Pre-Market Today? - Asianet Newsable
Why Is Kala Bio Stock Soaring Wednesday?Kala Bio (NASDAQ:KALA) - Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
KALA Announces Launch of First AI Product, Revolutionizing Biote - GuruFocus
Kala Bio Launches a Revolution for Biotech- First AI Agent Deploying in 14 Days as $180 Billion Agentic AI Healthcare Revolution Accelerates - Bitget
KALA BIO to launch first commercial AI agent in two weeks By Investing.com - Investing.com India
$180B AI healthcare play: KALA BIO pivots with first agent - Stock Titan
US Stocks Mixed; Dow Falls 300 Points - Sahm
Stock Trend Capital Provides Younet AI Investment Update - TMX Newsfile
Younet AI inks exclusive biotech platform deal with KALA BIO - Stock Titan
Dividend Watch: Will KALA BIO Inc benefit from sector rotationProduct Launch & Free Expert Verified Stock Movement Alerts - baoquankhu1.vn
$167 Billion Invested in Biotech R&D is Underserved by AI, Offering Huge Opportunity for New On-Premises AI Infrastructure Platform from KALA BIO, Inc. (Nasdaq: KALA) - Barchart.com
$167 Billion Invested in Biotech R&D is Underserved by AI, - openPR.com
Kala Bio Stock Soars 22% After Hours As Emergency Financing Deal Averts Asset Seizure After Eye Disease Drug Trial Collapse - Stocktwits
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
$167 Billion Pharma R&D Market Largely Untapped by AI Creates Major Growth Runway for KALA Bios Data-Sovereign AI Strategy: N A S D A Q: KALA - PRLog
KALA Unveils AI Platform to Revolutionize Biotech Data Managemen - GuruFocus
KALA Bio launches on-premises AI platform for biotech sector By Investing.com - Investing.com Australia
What's Going On With KALA BIO Stock Wednesday?Kala Bio (NASDAQ:KALA) - Benzinga
KALA Bio launches on-premises AI platform for biotech sector - Investing.com Nigeria
Kala Bio, Inc Announces Exclusive License Agreement with Younet Ai for Proprietary Ai Research Platform - marketscreener.com
Kala Bio Launches AI Platform for Biotech Industry - Data Center Knowledge
KALA BIO Secures Exclusive Researgency AI Platform License - TipRanks
Kala Bio Inc (KALA) 財務データ
収益
当期純利益
現金流量
EPS
0.99%
3.03%
大文字化:
|
ボリューム (24 時間):